Meeting Coverage:

American Academy of Ophthalmology

AAO: 2024

Presbyopia-Correcting IOLs: New Categories?

Show Description +

At the American Academy of Ophthalmology annual meeting, Daniel H. Chang, MD, presented on the categorization of presbyopia-correcting IOLs. He also describes why the Tecnis Odyssey (Johnson & Johnson Vision) is his first-line treatment for providing quality vision while minimizing dysphotopsias.

Posted: 10/25/2024

Up Next


Glaucoma Lasers: What’s New?

Sarah Van Tassel, MD

Visual Field Progression in the LiGHT Trial

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Updates on a Novel Oral Therapy for DME

Joel A. Pearlman, MD, PhD

The Promise of a Wnt Agonist

Charles C. Wykoff, MD, PhD

The Risk of PVR Revealed

Mathew W. MacCumber, MD, PHD

The 2024 Charles L Schepens MD Lecture

Steve Charles, MD, FACS, FICS

Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy

Arshad M. Khanani, MD, MA, FASRS

Presbyopia-Correcting IOLs: New Categories?

At the American Academy of Ophthalmology annual meeting, Daniel H. Chang, MD, presented on the categorization of presbyopia-correcting IOLs. He also describes why the Tecnis Odyssey (Johnson & Johnson Vision) is his first-line treatment for providing quality vision while minimizing dysphotopsias.

Posted: 10/25/2024


Please log in to leave a comment.

More From AAO: 2024 Coverage